Progress 07/01/21 to 10/27/22
Outputs Target Audience:This project has several target audiences. First, farmers of Bt-expressing crops, notably corn and cotton, are a major target for this product. These farmers are experiencing the resistance development in the corn earworm and the high cost of newer Bt traits. We have interacted directly with this audience at AgLaunch Field days in the summer of 2021 and 2022. Several farmers are also investors in Lepidext. Lepidext has also been in communication with the agrichemical companies that have developed Bt traits. There are varied responses to our new technology which Lepidext believes can extend the utility of Bt traits. Lepidext is also in regular communication with both actual and prospective investors regarding this technology individually and through investor forums. Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?This project supported four undergraduate students. One of the undergraduate students joined our lab upon completion of her degree from the Agricultural and Medical Biotechnolgy program at the University of Kentucky. How have the results been disseminated to communities of interest?Lepidext participated at AgLaunch Field Day 2021 and 2022 in Savannah, TN. A video of Dr. Webb's presentation is available on-line on YouTube (https://www.youtube.com/watch?v=6FrkECRE3fI). What do you plan to do during the next reporting period to accomplish the goals?
Nothing Reported
Impacts What was accomplished under these goals?
Two experiments showed that Bt-resistant and susceptible insects were equally susceptible to the effects of InsterusHz. Susceptible insects, as expected, showed higher mortality when fed Bt diets than resistant insects and Bt resistant insects were developmentally delayed when fed upon Bt diets as has been reported in the literature. A population model was developed that indicated that it would be possible to target Bt resistant insects by taking advantage of the developmental delays caused by exposure to Bt. This was proposed in a Phase 2 submission which was not funded.
Publications
|
Progress 07/01/21 to 06/30/22
Outputs Target Audience:This project has several target audiences. First, farmers of Bt-expressing crops, notably corn and cotton, are a major target for this product. These farmers are experiencing the resistance development in the corn earworm and the high cost of newer Bt traits. We have interacted directly with this audience at AgLaunch Field days in the summer of 2021 and 2022. Several farmers are also investors in Lepidext. Lepidext has also been in communication with the agrichemical companies that have developed Bt traits. There are varied responses to our new technology which Lepidext believes can extend the utility of Bt traits. Lepidext is also in regular communication with both actual and prospective investors regarding this technology individually and through investor forums. Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?This project supported four undergraduate students. One of the undergraduate students joined our lab upon completion of her degree from the Agricultural and Medical Biotechnolgy program at the University of Kentucky. How have the results been disseminated to communities of interest?Lepidext participated at AgLaunch Field Day 2021 and 2022 in Savannah, TN. A video of Dr. Webb's presentation is available on-line on YouTube (https://www.youtube.com/watch?v=6FrkECRE3fI). What do you plan to do during the next reporting period to accomplish the goals?
Nothing Reported
Impacts What was accomplished under these goals?
Two experiments showed that Bt-resistant and susceptible insects were equally susceptible to the effects of InsterusHz. Susceptible insects, as expected, showed higher mortality when fed Bt diets than resistant insects and Bt resistant insects were developmentally delayed when fed upon Bt diets as has been reported in the literature. A population model was developed that indicated that it would be possible to target Bt resistant insects by taking advantage of the developmental delays caused by exposure to Bt. This was proposed in a Phase 2 submission which was not funded.
Publications
|
|